Bayer’s ‘Next’ big thing

Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI. The Contour Next portfolio includes an entry meter, Contour Next EZ, for the newly diagnosed diabetic. For the experienced tester, there is the traditional Contour Next. And for the technologically savvy tester, there’s the Contour Next USB.

(For the complete category review, including data, click here.)